在ESCMID全球2025会议上，Bruker的微生物学和感染诊断部门宣布，其微生物学解决方案将其扩展到下一代测序（NGS）应用中，仅在流行病学和医院收购感染（HAI）跟踪中，仅新的，研究的基于NGS的NGS解决方案。鲁克（Ruker）与Ridom GmbH进行了NGS生物信息学应用程序的战略合作，总部位于德国Muenster ...
At the ESCMID Global conference, Bruker announced a significant menu expansion of its validated PCR assays on its BeGenius® sample-to-answer molecular diagnostics system, as well as automated sample preparation improvements for near-universal microbial identification by the MALDI Biotyper® platform,
